EUVIMEDEUVIMED entdecken
Crossref

Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals

The Egyptian Journal of Hospital Medicine · 01.10.2026 · 105 (1) · 6585-6591

DOI: 10.21608/ejhm.2026.536663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.10.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals. The Egyptian Journal of Hospital Medicine, 105(1), 6585-6591. https://doi.org/10.21608/ejhm.2026.536663

Vancouver

Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals. The Egyptian Journal of Hospital Medicine. 2026;105(1):6585-6591. doi:10.21608/ejhm.2026.536663

BibTeX
@article{euvimed2026,
  title = {Utility of Myeloperoxidase and Soluble CD40 Ligand in Predicting Acute Coronary Syndrome at Menoufia University Hospitals},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {105},
  number = {1},
  pages = {6585--6591},
  doi = {10.21608/ejhm.2026.536663}
}
Kostenlos starten →